Patrick Johnson

Johnson is president of Sydnexis Inc., a clinical-stage biopharmaceutical company focused on macular degeneration. Previously, he was head of business development for eye care and drug delivery at Allergan and co-founder of Cimeros, a drug delivery startup company. He is a former adjunct professor in the Department of Molecular Biology at the University of California.

  • October 2023

Added to: Aviceda Therapeutics - Cambridge, MA

Aviceda Therapeutics is a clinical-stage biotechnology company focused on the treatment of patients with geographic atrophy.